Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Petr Mukensnabl"'
Publikováno v:
Onkologie. 14:40-43
Nase kazuistika popisuje připad nekuřaka s generalizovaným plicnim adenokarcinomem s ALK translokaci. Po uvodnich dvou liniich chemoterapie byl ziskan přistup ke crizotinibu, na kterem brzy doslo ke vzniku drobne druhostranne leze, vyhodnocene ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4e58fc3089f1dd76a0ce97d416cdb74
https://doi.org/10.36290/xon.2020.035
https://doi.org/10.36290/xon.2020.035
Autor:
Jiri Blazek, Tomas Vanecek, Jan Baxa, Petr Mukensnabl, Martin Svaton, Miloš Pešek, Gabriela Krakorova
Publikováno v:
Translational Cancer Research
The onset of routine use of the next generation sequencing (NGS) leads to discovery of new mutations in non-small cell lung cancer (NSCLC). In addition, comprehension of therapeutic potential of these genetic alterations in clinical practice is neede
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f2cdad5935925849632e5813e9872b
http://europepmc.org/articles/PMC8797612
http://europepmc.org/articles/PMC8797612
Autor:
Marián Švajdler, Bohuslava Šašková, Michal Michal, Petr Mukensnabl, Roman Mezencev, Ondrej Ondič
Publikováno v:
Human Pathology. 85:58-64
Pulmonary small cell carcinoma (SCLC) can be usually diagnosed based on the morphological evaluation of routine histological or cytological preparations. However, immunohistochemistry may be also necessary in problematic cases. Insulinoma-associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c6c3a02f808e80c33d84ba12307a8df
https://doi.org/10.1016/j.humpath.2018.10.016
https://doi.org/10.1016/j.humpath.2018.10.016
Autor:
Josef Vodicka, Š Vejvodová, Petr Mukensnabl, Vladimir Spidlen, Martin Pesta, Vlastimil Kulda, Ondrej Topolcan
Publikováno v:
Journal of Surgical Oncology. 117:163-170
BACKGROUND Detection of tumor cells in lymph nodes (LNs) removed during the treatment of pulmonary tumor by radical surgery is limited by the possibilities of standard histopathological methods. The goal of this study was to obtain more accurate pTNM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f0f08cf1602aabac9166ca23f6a03d1
https://doi.org/10.1002/jso.24826
https://doi.org/10.1002/jso.24826
Autor:
Josef Vodicka, Š Vejvodová, Gabriela Krakorova, Vladimir Spidlen, Petr Mukensnabl, Jiri Molacek
Publikováno v:
Annals of Thoracic and Cardiovascular Surgery. 23:12-18
Purpose solitary fibrous tumors (SFT) represent a heterogeneous group of primary pleural neoplasms with a low incidence rate and of which the biological origin, which consists of mesenchymal cells, is uncertain. Methods The authors present herewith a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae4cc3f752c5e3e5c340ff7a89d2de8
https://doi.org/10.5761/atcs.oa.16-00108
https://doi.org/10.5761/atcs.oa.16-00108
Autor:
Martin, Svaton, Ondrej, Fiala, Gabriela, Krakorova, Jiri, Blazek, Karolina, Hurdalkova, Magda, Barinova, Petr, Mukensnabl, Milos, Pesek
Publikováno v:
Oncology Letters
While erlotinib is primarily administered to patients with non-small cell lung cancer with sensitizing epidermal growth factor receptor (EGFR) mutations, it is also prescribed to patients with wild type (wt) EGFR in higher lines of treatment. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2baadbe8e65ce55a1d1722a96de8ac60
https://pubmed.ncbi.nlm.nih.gov/32724380
https://pubmed.ncbi.nlm.nih.gov/32724380
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 31(1)
Background Patients with sensitive EGFR mutations are already being treated with first and second generation tyrosine kinase inhibitors (TKIs). However, resistance to these drugs occurs over time, and over half of all cases is caused by a mutation (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f333f01672138cca137a9c95fcc52938
https://pubmed.ncbi.nlm.nih.gov/29488779
https://pubmed.ncbi.nlm.nih.gov/29488779
Publikováno v:
Dermatologic Therapy. 28:369-372
A case is described of severe acute hepatitis in 47-year-old woman with chronic psoriasis and psoriatic arthritis treated with infliximab. Although clinical, serological and laboratory results were compatible with acute EBV hepatitis, it was difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe89cdf2267fc850747c9e2698419a03
https://doi.org/10.1111/dth.12271
https://doi.org/10.1111/dth.12271
Autor:
Vaclav Babuska, Radana Vrzakova, Zbynek Houdek, Martin Svaton, Vlastimil Kulda, Petr Mukensnabl, Martin Pesta, Miloš Pešek, Katerina Houfkova, Pavel Dvorak, Kristyna Hrda
Publikováno v:
Oncology Letters.
Attributing to their pathophysiological role and stability in biological samples, microRNAs (miRNAs) have the potential to become valuable predictive markers for non-small cell lung cancer (NSCLC). Samples of biopsy tissue constitute suitable materia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71967ad86144ac0e139519b4ffa5a799
https://doi.org/10.3892/ol.2017.7337
https://doi.org/10.3892/ol.2017.7337
Publikováno v:
Journal of Cranio-Maxillofacial Surgery. 42:93-100
Background Langerhans cell histiocytosis is a rare disease characterized by monoclonal proliferation and migration of special dendritic cells. This disease primarily affects bones, but occurs less frequently in other organ systems or may manifest as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2ef6fb4bb6214352c7a480e7299428
https://doi.org/10.1016/j.jcms.2013.03.005
https://doi.org/10.1016/j.jcms.2013.03.005